DK431589D0 - Saarbehandlingsmidler indeholdende thromboxan a2-receptor-antagonister - Google Patents
Saarbehandlingsmidler indeholdende thromboxan a2-receptor-antagonisterInfo
- Publication number
- DK431589D0 DK431589D0 DK431589A DK431589A DK431589D0 DK 431589 D0 DK431589 D0 DK 431589D0 DK 431589 A DK431589 A DK 431589A DK 431589 A DK431589 A DK 431589A DK 431589 D0 DK431589 D0 DK 431589D0
- Authority
- DK
- Denmark
- Prior art keywords
- thromboxan
- spare
- receptor antagonists
- treatments containing
- treatments
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 208000028990 Skin injury Diseases 0.000 abstract 1
- 229940123987 Thromboxane A2 receptor antagonist Drugs 0.000 abstract 1
- 239000003769 thromboxane A2 receptor blocking agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/239,376 US4925873A (en) | 1988-09-01 | 1988-09-01 | Method of treating skin injuries using thromboxane A2 receptor antagonists |
US23937688 | 1988-09-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK431589D0 true DK431589D0 (da) | 1989-08-31 |
DK431589A DK431589A (da) | 1990-03-02 |
DK175207B1 DK175207B1 (da) | 2004-07-12 |
Family
ID=22901897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198904315A DK175207B1 (da) | 1988-09-01 | 1989-08-31 | Sårbehandlingsmidler indeholdende thromboxan A2-receptor-antagonister |
Country Status (13)
Country | Link |
---|---|
US (1) | US4925873A (da) |
EP (1) | EP0357030B1 (da) |
JP (1) | JPH02108635A (da) |
AT (1) | ATE100320T1 (da) |
AU (1) | AU632503B2 (da) |
CA (1) | CA1337930C (da) |
DE (1) | DE68912459T2 (da) |
DK (1) | DK175207B1 (da) |
HU (1) | HUT51137A (da) |
IE (1) | IE63799B1 (da) |
NZ (1) | NZ230505A (da) |
PT (1) | PT91597B (da) |
ZA (1) | ZA896558B (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5858684A (en) * | 1991-08-23 | 1999-01-12 | The Brigham And Women's Hospital, Inc. | Method of screening calcium receptor-active molecules |
US6011068A (en) * | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US5763569A (en) * | 1991-08-23 | 1998-06-09 | The Brigham And Women's Hospital, Inc | Calcium receptor-active molecules |
US5688938A (en) * | 1991-08-23 | 1997-11-18 | The Brigham & Women's Hospital, Inc. | Calcium receptor-active molecules |
US6001884A (en) * | 1991-08-23 | 1999-12-14 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US6031003A (en) * | 1991-08-23 | 2000-02-29 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US6313146B1 (en) | 1991-08-23 | 2001-11-06 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US5324746A (en) * | 1993-02-12 | 1994-06-28 | Mckee Rex N | Method of treating damaged mucosal and epithelial tissues with misoprostol |
US5962314A (en) * | 1993-02-23 | 1999-10-05 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
WO1995011699A1 (en) * | 1993-10-29 | 1995-05-04 | The Trustees Of Boston University | Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
GB9424708D0 (en) * | 1994-12-07 | 1995-02-01 | Bristol Myers Squibb Co | Use of inflammatory modulators in the treatment of chronic or recalcitrant skin damage |
DK1203761T3 (da) | 1994-12-08 | 2005-04-11 | Nps Pharma Inc | Calciumreceptoraktive forbindelser |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
DK0907631T3 (da) | 1996-05-01 | 2003-09-22 | Nps Pharma Inc | Uorganiske ionreceptoraktive forbindelser |
US5994399A (en) * | 1997-03-27 | 1999-11-30 | Mckee; Rex N. | Method of regenerating collagen-containing tissues with misoprostol |
AU774861B2 (en) * | 1998-02-11 | 2004-07-08 | Douglas V Faller | Compositions and methods for the treatment of cystic fibrosis |
US7241746B2 (en) * | 2003-08-06 | 2007-07-10 | Regena Therapeutics, Lc | Method and composition for treating periodontal disease |
WO2010105112A1 (en) * | 2009-03-11 | 2010-09-16 | Hemaquest Pharmaceuticals, Inc. | Detection of short-chain fatty acids in biological samples |
WO2011038224A1 (en) | 2009-09-24 | 2011-03-31 | Trustees Of Boston University | Methods for treating viral disorders |
WO2011072086A1 (en) | 2009-12-08 | 2011-06-16 | Hemaquest Pharmaceuticals, Inc. | Methods and low dose regimens for treating red blood cell disorders |
WO2011113013A2 (en) | 2010-03-11 | 2011-09-15 | Hemaquest Pharmaceuticals, Inc. | Methods and compositions for treating viral or virally-induced conditions |
WO2012105823A1 (en) | 2011-02-02 | 2012-08-09 | Biotropics Malaysia Berhad | Cosmetic non therapeutic use of extracts from ficus deltoidea |
AU2020283590A1 (en) | 2019-05-31 | 2022-01-20 | Viracta Subsidiary, Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2809377A1 (de) * | 1978-03-04 | 1979-09-13 | Boehringer Mannheim Gmbh | Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
DE3000377A1 (de) * | 1980-01-07 | 1981-07-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
US4537981A (en) * | 1981-11-09 | 1985-08-27 | E. R. Squibb & Sons, Inc. | 7-Oxabicycloheptane and 7-oxabicycloheptene compounds |
US4416896A (en) * | 1982-05-17 | 1983-11-22 | E. R. Squibb & Sons, Inc. | 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease |
US4663336A (en) * | 1985-07-01 | 1987-05-05 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease |
US4673685A (en) * | 1986-07-23 | 1987-06-16 | E. R. Squibb & Sons, Inc. | Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease |
US4752616A (en) * | 1987-06-29 | 1988-06-21 | E. R. Squibb & Sons, Inc. | Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use |
-
1988
- 1988-09-01 US US07/239,376 patent/US4925873A/en not_active Expired - Fee Related
-
1989
- 1989-08-22 CA CA000609039A patent/CA1337930C/en not_active Expired - Fee Related
- 1989-08-28 ZA ZA896558A patent/ZA896558B/xx unknown
- 1989-08-28 IE IE275589A patent/IE63799B1/en not_active IP Right Cessation
- 1989-08-30 EP EP89116002A patent/EP0357030B1/en not_active Expired - Lifetime
- 1989-08-30 AT AT89116002T patent/ATE100320T1/de not_active IP Right Cessation
- 1989-08-30 DE DE68912459T patent/DE68912459T2/de not_active Expired - Lifetime
- 1989-08-30 AU AU40898/89A patent/AU632503B2/en not_active Ceased
- 1989-08-31 DK DK198904315A patent/DK175207B1/da not_active IP Right Cessation
- 1989-08-31 HU HU894522A patent/HUT51137A/hu unknown
- 1989-08-31 JP JP1228178A patent/JPH02108635A/ja active Pending
- 1989-08-31 PT PT91597A patent/PT91597B/pt not_active IP Right Cessation
- 1989-08-31 NZ NZ230505A patent/NZ230505A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT91597A (pt) | 1990-03-30 |
EP0357030A2 (en) | 1990-03-07 |
CA1337930C (en) | 1996-01-16 |
NZ230505A (en) | 1997-03-24 |
DE68912459D1 (de) | 1994-03-03 |
PT91597B (pt) | 1995-05-04 |
AU4089889A (en) | 1990-03-08 |
AU632503B2 (en) | 1993-01-07 |
EP0357030B1 (en) | 1994-01-19 |
DK431589A (da) | 1990-03-02 |
IE892755L (en) | 1990-03-01 |
ATE100320T1 (de) | 1994-02-15 |
US4925873A (en) | 1990-05-15 |
JPH02108635A (ja) | 1990-04-20 |
ZA896558B (en) | 1990-05-30 |
DK175207B1 (da) | 2004-07-12 |
IE63799B1 (en) | 1995-06-14 |
EP0357030A3 (en) | 1990-08-16 |
HUT51137A (en) | 1990-04-28 |
DE68912459T2 (de) | 1994-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK431589A (da) | Saarbehandlingsmidler indeholdende thromboxan a2-receptor-antagonister | |
ES2169127T3 (es) | Nuevos carbamatos y ureas como modificadores de la resistencia multi-farmaco. | |
IT8167845A0 (it) | Composizione per il trattamento topico dell'acne | |
IT8147606A0 (it) | Composizione per il trattamento topico dell'acne | |
DE59304351D1 (de) | Neue therapeutische Verwendungen von Phthalazinon-Derivaten | |
ATE91623T1 (de) | Verwendung von serotonin-antagonisten bei der behandlung von apoplexia cerebri. | |
DK90089D0 (da) | Hudbehandlingspraeparat | |
IT1221826B (it) | Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi | |
DK71387A (da) | Terapeutisk middel til behandling af psoriasis | |
ATE194919T1 (de) | Verwendung von dibutyl-adipat und isopropyl- myristat in topischen und transdermalen produkten | |
ATE187642T1 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
IT8320435A0 (it) | Composizione per il trattamento dell'acne. | |
ES2080736T3 (es) | Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos. | |
DE68906707D1 (de) | 3-substituierte 2-oxindol-1-carboxamid-derivate zur hemmung der aktivitaet der t-zellen. | |
DE68912376T2 (de) | Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie. | |
FI954614A0 (fi) | Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina | |
DK277387A (da) | Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom | |
IT1209547B (it) | Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico. | |
ITMI912224A1 (it) | Impiego di composti adenosinici nel trattamento dell'ischemia | |
MX9203362A (es) | Composicion diuretica de benazepril/tiazida de dosis baja, para el tratamiento de la hipertension | |
DE59305285D1 (de) | Transdermales therapeutisches system mit pentylentetrazol als wirkstoff | |
DE69806098D1 (de) | yerwendung von einer 2-aroyl-3-arylbenzo(b)thiophen Verbindung zur Senkung des Fibrinogens | |
IT1219592B (it) | Lozione riattivante per il trattamento dell' alopecia | |
ITRE920030A1 (it) | Dispositivo di comando del movimento dell'utensile nelle macchine per spaccare la legna | |
IT8647570A0 (it) | Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne giovanile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |
Country of ref document: DK |